Research
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5920 (Published 15 October 2014) Cite this as: BMJ 2014;349:g5920Related articles
- Research Published: 30 July 2020; BMJ 370 doi:10.1136/bmj.m2614
EditorialPredicting ovarian malignancy
See more
- An adolescent with disabling abdominal painBMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101
- Whole brain radiotherapy for brain metastasesBMJ December 05, 2016, 355 i6483; DOI: https://doi.org/10.1136/bmj.i6483
- Commitment to talking not just treatingBMJ December 05, 2016, 355 i6471; DOI: https://doi.org/10.1136/bmj.i6471
- Doctors need dragging out of their comfort zone to avert the antimicrobial crisis, says lordBMJ December 02, 2016, 355 i6517; DOI: https://doi.org/10.1136/bmj.i6517
- Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide studyBMJ November 30, 2016, 355 i5745; DOI: https://doi.org/10.1136/bmj.i5745
Cited by...
- Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer
- Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors
- Suicide risk assessment tools and prediction models: new evidence, methodological innovations, outdated criticisms
- Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements
- ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies
- The ADNEX risk prediction model for ovarian cancer diagnosis: A systematic review and meta-analysis of external validation studies
- The Use of Machine Learning Models and Radiomics for Segmentation and Classification of Adnexal Masses on Ultrasound: A multi-cohort retrospective study
- Psychological impact of referral to an oncology hospital on patients with an ovarian mass
- Extramedullary haematopoiesis presenting as an adnexal mass in a patient with {beta}-thalassaemia
- Ultrasound, macroscopic and histological features of malignant ovarian tumors. Metastatic tumors to the ovary: ovarian metastases from biliary tract and ovarian metastases from colon cancer
- Ultrasound, macroscopic and histological features of malignant ovarian tumors. Non-epithelial ovarian carcinomas: tubal choriocarcinoma and granulosa cell tumor
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
- Ultrasound, macroscopic and histological features of endometrioid and clear cell ovarian cancer
- Management of ovarian masses in pregnancy: patient selection for interventional treatment
- Ultrasound, macroscopic and histological features of serous epithelial ovarian carcinomas
- Ultrasound, macroscopic and histological features of borderline ovarian tumors
- Ultrasound, macroscopic and histological features of malignant ovarian tumors
- Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
- Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors
- Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center
- Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort
- Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
- Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer
- Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer
- Authors' reply to Candido-dos-Reis
- Predicting ovarian malignancy